Cite
Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma
MLA
Michael Weller, et al. “Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma.” Cancers, vol. 13, no. 12, June 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cc52795a76bf8cf8ed6fdee175136db7&authtype=sso&custid=ns315887.
APA
Michael Weller, Patrick Roth, Hans-Georg Wirsching, & Stefan Balabanov. (2021). Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma. Cancers, 13(12).
Chicago
Michael Weller, Patrick Roth, Hans-Georg Wirsching, and Stefan Balabanov. 2021. “Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma.” Cancers 13 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cc52795a76bf8cf8ed6fdee175136db7&authtype=sso&custid=ns315887.